CRMDCorMedix Inc.

$536M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88,261+19.2% YoY

Gross Profit

$26,92230.5% margin

Operating Income

-$7M-8169.5% margin

Net Income

-$7M-8176.8% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+58.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$84M

Total Liabilities

$4M

Stockholders' Equity

$80M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88,261	$74,054	+19.2%
Gross Profit	$26,922	$25,537	+5.4%
Operating Income	-$7M	-$6M	-28.5%
Net Income	-$7M	-$6M	-29.9%

CRMD Q1 2021 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena